RecruitingNCT05177523

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

INsIDER: Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis


Sponsor

University Hospital, Basel, Switzerland

Enrollment

300 participants

Start Date

Sep 4, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

This project is to: 1. Quantify differences in axonal integrity and organization in aMS versus naPMS patients. 2. Quantify changes in axonal integrity and organization in aMS versus naPMS patients over a two-year period. 3. Validate the combination of imaging parameters that best differentiate aMS versus naPMS patients using histopathology.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria7

  • Patients may be diagnosed with:
  • active RRMS (n=100): Relapsing-remitting course and \> 1 clinical relapse and/or signs of MRI activity (\> 1 Gd enhancing lesion) during the last year before study enrollment.
  • non-active PMS (n=100): Progressive course (PPMS or SPMS) and no clinical relapses and/or signs of MRI activity during the last year before study enrollment.
  • Age 18-80 years old
  • No other neurological or psychiatric disorder
  • Age 18-80 years old
  • No other neurological or psychiatric disorder

Exclusion Criteria3

  • Pregnancy
  • Contraindication to MRI (eg, claustrophobia, metallic implants, pacemaker etc).
  • Inability to give consent

Interventions

DIAGNOSTIC_TESTMRI

Each enrolled subject will undergo a MRI at baseline and a second MRI at 2 years (+/- 3 months) follow-up.

OTHERNeurocognitive examination for healthy subjects

Neurocognitive examination for healthy subjects will be performed at both baseline and follow-up

OTHERblood sampling

Each enrolled subject will undergo a blood sampling (10 ml) at baseline


Locations(1)

University Hospital Basel, Department of Neurology

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05177523


Related Trials